Metabolic Abnormalities in Pain-Processing Regions of Patients with Fibromyalgia: A 3T MR Spectroscopy Study

References

1. 1.↵
   1. Wolfe F,
   2. Ross K,
   3. Anderson J,
   4. et al

   . The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19–28

   PubMedWeb of Science
2. 2.↵
   1. Wolfe F,
   2. Smythe HA,
   3. Yunus MB,
   4. et al

   . The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160–72

   PubMedWeb of Science
3. 3.↵
   1. Cohen H,
   2. Neumann L,
   3. Shore M,
   4. et al

   . Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Semin Arthitis Rheum 2000; 29: 217–27

   CrossRef
4. 4.↵
   1. Park DC,
   2. Glass JM,
   3. Minear M,
   4. et al

   . Cognitive function in fibromyalgia patients. Arthritis Rheum 2001; 44: 2125–33

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Wolfe F

   . The fibromyalgia problem. J Rheumatol 1997; 24: 1247–49

   PubMedWeb of Science
6. 6.↵
   1. Clauw DJ,
   2. Chrousos GP

   . Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenetic mechanism. Neuroimmunomodulation 1997; 4: 134–53

   PubMedWeb of Science
7. 7.↵
   1. Peyron R,
   2. Laurent B,
   3. Garcia-Larrea L

   . Functional imaging of brain responses to pain: a review and meta-analysis. Neurophysiol Clin 2000; 30: 263–88

   PubMedWeb of Science
8. 8.↵
   1. Guedj E,
   2. Taieb D,
   3. Cammilleri S,
   4. et al

   . 99m tc-ECD brain perfusion SPECT in hyperalgesic fibromyalgia. Eur J Nucl Med Mol Imaging 2006; 34: 130–34. Epub 2006 Aug 25

   PubMed
9. 9.↵
   1. Gur A,
   2. Karakoc M,
   3. Erdogan S,
   4. et al

   . Regional cerebral blood flow and cytokines in young females with fibromyalgia. Clin Exp Rheumatol 2002; 20: 753–60

   PubMed
10. 10.↵
    1. Kwiatek R,
    2. Barnden L,
    3. Tedman R,
    4. et al

    . Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000;43:2823–33

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Mountz JM,
    2. Bradley LA,
    3. Modell JG,
    4. et al

    . Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995; 38: 926–38

    PubMedWeb of Science
12. 12.↵
    1. Yunus MB,
    2. Young CS,
    3. Saeed SA,
    4. et al

    . Positron emission tomography in patients with fibromyalgia syndrome and healthy controls. Arthritis Rheum 2004; 51: 513–18

    CrossRefPubMed
13. 13.↵
    1. Iadarola MJ,
    2. Max MB,
    3. Berman KF,
    4. et al

    . Unilateral decrease in thalamic activity observed with positron emission tomography in patients with chronic neuropathic pain. Pain 1995; 63: 55–64

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Gracely RH,
    2. Petzke F,
    3. Wolf JM,
    4. et al

    . Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46: 1333–43

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Gracely RH,
    2. Geisser ME,
    3. Giesecke T,
    4. et al

    . Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004; 127: 835–43. Epub 2004 Feb 11

    Abstract/FREE Full Text
16. 16.↵
    1. Cook DB,
    2. Lange G,
    3. Ciccone DS,
    4. et al

    . Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004; 31: 364–78

    Abstract/FREE Full Text
17. 17.↵
    1. Petrovic P,
    2. Kalso E,
    3. Petersson KM,
    4. et al

    . Placebo and opioid analgesia: imaging a shared neuronal network. Science 2002; 295: 1737–40

    Abstract/FREE Full Text
18. 18.↵
    1. Wager TD,
    2. Rilling JK,
    3. Smith EE,
    4. et al

    . Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 2004; 303: 1162–67

    Abstract/FREE Full Text
19. 19.↵
    1. Lieberman MD,
    2. Jarcho JM,
    3. Berman S,
    4. et al

    . The neural correlates of placebo effects: a disruption account. Neuroimage 2004; 22: 447–55

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Salomons TV,
    2. Johnstone T,
    3. Backonja MM,
    4. et al

    . Individual differences in the effects of perceived controllability on pain perception: critical role of the prefrontal cortex. J Cogn Neurosci 2007; 19: 993–1003

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Wood PB,
    2. Ledbetter CR,
    3. Glabus MF,
    4. et al

    . Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features. J Pain 2009; 10: 47–52

    PubMedWeb of Science
22. 22.↵
    1. Emad Y,
    2. Ragab Y,
    3. Zeinhom F,
    4. et al

    . Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome: a study with single-voxel magnetic resonance spectroscopy. J Rheumatol 2008; 35: 1371–77

    Abstract/FREE Full Text
23. 23.↵
    1. Petrou M,
    2. Harris RE,
    3. Foerster BR,
    4. et al

    . Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity. AJNR Am J Neuroradiol 2008; 29: 913–18

    Abstract/FREE Full Text
24. 24.↵
    1. Harris RE,
    2. Sundgren PC,
    3. Pang Y,
    4. et al

    . Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 2008; 58: 903–07

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Harris RE,
    2. Sundgren PC,
    3. Craig AD,
    4. et al

    . Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009; 60:3146–52

    CrossRefPubMed
26. 26.↵
    1. Valdés M,
    2. Collado A,
    3. Bargallò N,
    4. et al

    . Increased glutamate-glutamine compounds in the brain of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum 2010; 62: 1829–36

    CrossRefPubMed
27. 27.↵
    1. Fayed N,
    2. Garcia-Campayo J,
    3. Magallón R,
    4. et al

    . Localized ¹H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis Res Ther 2010:7:12:R134. Epub 2010 Jul 7
28. 28.↵
    1. Burckhardt CS,
    2. Clark SR,
    3. Bennett RM

    . The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991; 18: 728–33

    PubMedWeb of Science
29. 29.↵
    1. Provencher SW

    . Estimation of metabolite concentrations from localized in vivo NMR spectra. Magn Reson Med 1993; 30: 672–79

    PubMedWeb of Science
30. 30.↵
    1. Bleich S,
    2. Römer K,
    3. Wiltfang J

    . Glutamate and the glutamate receptor system: a target for drug action. Int J Geriatr Psychiatry 2003; 18: 33–40

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Yang JW,
    2. Shih HC,
    3. Shyu BC

    . Intracortical circuits in rat anterior cingulate cortex are activated by nociceptive inputs mediated by medial thalamus. J Neurophysiol 2006; 96: 3409–22. Epub 2006 Sep 6

    Abstract/FREE Full Text
32. 32.↵
    1. Zhang L,
    2. Zhang Y,
    3. Zhao ZQ

    . Anterior cingulate cortex contributes to descending facilitatory modulation of pain via dorsal reticular nucleus. Eur J Neurosci 2005; 22: 1141–48

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Johansen JP,
    2. Fields HL

    . Glutamatergic activation of anterior cingulate cortex produces an aversive teaching signal. Nat Neurosci 2004; 7: 398–403. Epub 2004 Mar 7

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Mullins PG,
    2. Rowland LM,
    3. Jung RE,
    4. et al

    . A novel technique to study the brain's response to pain: proton magnetic resonance spectroscopy. Neuroimage 2005; 26: 642–46

    CrossRefPubMed
35. 35.↵
    1. Petrovic P,
    2. Kalso E,
    3. Petersson KM,
    4. et al

    . A prefrontal non-opioid mechanism in placebo analgesia. Pain 2010; 150: 59–65

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Badre D,
    2. Wagner AD

    . Left ventrolateral prefrontal cortex and the cognitive control of memory. Neuropsychologia 2007; 45: 2883–901

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Metz AE,
    2. Yau HJ,
    3. Centeno MV,
    4. et al

    . Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain. Proc Natl Acad Sci U S A 2009; 106: 2423–28

    Abstract/FREE Full Text
38. 38.↵
    1. Isaacks RE,
    2. Bender AS,
    3. Kim CY,
    4. et al

    . Osmotic regulation of myo-inositol uptake in primary astrocyte cultures. Neurochem Res 1994; 19: 331–38

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Sarchielli P,
    2. Mancini ML,
    3. Floridi A,
    4. et al

    . Increased levels of neurotrophins are not specific for chronic migraine: evidence from primary fibromyalgia syndrome. J Pain 2007; 9: 737–45. Epub 2007 Jul 5
40. 40.↵
    1. Bohr TW

    . Fibromyalgia syndrome and myofascial pain syndrome: do they exist? Neurol Clin 1995; 13: 365–84

    PubMedWeb of Science